Bank of Montreal’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-110,192
Closed -$1.08M 3839
2021
Q3
$1.08M Buy
110,192
+910
+0.8% +$8.44K ﹤0.01% 2443
2021
Q2
$1.43M Buy
+109,282
New +$1.07M ﹤0.01% 2269
2018
Q3
Sell
-200
Closed -$34K 4872
2018
Q2
$34K Buy
+200
New +$54.8K ﹤0.01% 3568
2018
Q1
Hold
0
4315
2017
Q4
Hold
0
4316
2017
Q1
Sell
-1
Closed -$2K 4168
2016
Q4
$2K Buy
+1
New +$5.82K ﹤0.01% 3897

Other funds holding SLS

Bank of Montreal's SLS Position: Q4 2021 in Review

Bank of Montreal sold out of SELLAS Life Sciences (SLS) in Q4 2021, closing a stake of 110,192 shares — an estimated $1.08M sold.

Bank of Montreal first reported a position in SLS in Q4 2016 and held it in 4 quarters. The position peaked at $1.43M in Q2 2021. 27 funds tracked by Wall St. Rank hold SLS as of Q4 2021.

  • Bank of Montreal reported no remaining SELLAS Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 110,192 SELLAS Life Sciences shares in Q4 2021, an estimated $1.08M.
  • Bank of Montreal first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 4 quarters.
  • Bank of Montreal's SELLAS Life Sciences position peaked at $1.43M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.